HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C-Reactive Protein Promotes the Activation of Fibroblast-Like Synoviocytes From Patients With Rheumatoid Arthritis.

Abstract
Objective: To evaluate the biological effect and mechanisms of C-reactive protein (CRP) on the activation of fibroblast-like synoviocytes (FLSs) from patients with rheumatoid arthritis (RA). Study design: To understand if CRP is involved in RA, expression of CRP and its receptors CD32/64 was examined in synovial tissues from RA patients and normal controls. In vitro, the potential role and mechanisms of CRP in FLS proliferation and invasion, expression of pro-inflammatory cytokines, and activation of signaling pathways were investigated in both RA - FLS and a normal human fibroblast-like synoviocyte line (HFLS). Results: Compared to normal controls, synovial tissues from 21 RA patients exhibited highly activated CRP signaling, particularly by FLSs as identified by 65% of CRP-expressing cells being CRP+vimentin+ and CD32/64+vimentin+ cells. In vitro, FLSs from RA patients, but not HFLS, showed highly reactive to CRP by largely increasing proliferative and invasive activities and expressing pro-inflammatory cytokines and chemokines, including CCL2, CXCL8, IL-6, and MMP2/9. All these changes were blocked largely by a neutralizing antibody to CD32 and, to a less extent by the anti-CD64 antibody, revealing CD32 as a primary mechanism of CRP signaling during synovial inflammation. Further studies revealed that CRP also induced synovial inflammation differentially via CD32/CD64- NF-κB or p38 pathways as blockade of CRP-CD32-NF-κB signaling inhibited CXCL8, CCL2, IL-6, whereas CRP induced RA-FLS invasiveness through CD32-p38 and MMP9 expression via the CD64-p38-dependent mechanism. Conclusions: CRP signaling is highly activated in synovial FLSs from patients with RA. CRP can induce synovial inflammation via mechanisms associated with activation of CD32/64-p38 and NF-κB signaling.
AuthorsZhengyu Fang, Jiyang Lv, Jing Wang, Qingxia Qin, Juan He, Meiying Wang, Gengmin Zhou, Guoyu Liu, Fubo Zhong, Yadan Zheng, Hui-Yao Lan, Qingwen Wang
JournalFrontiers in immunology (Front Immunol) Vol. 11 Pg. 958 ( 2020) ISSN: 1664-3224 [Electronic] Switzerland
PMID32508836 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2020 Fang, Lv, Wang, Qin, He, Wang, Zhou, Liu, Zhong, Zheng, Lan and Wang.
Chemical References
  • CRP protein, human
  • Cytokines
  • NF-kappa B
  • Receptors, IgG
  • Receptors, Immunologic
  • C-Reactive Protein
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Adult
  • Arthritis, Rheumatoid (metabolism, pathology)
  • C-Reactive Protein (metabolism, pharmacology)
  • Case-Control Studies
  • Cell Movement
  • Cell Proliferation
  • Cells, Cultured
  • Cytokines (metabolism)
  • Female
  • Humans
  • Male
  • Middle Aged
  • NF-kappa B (metabolism)
  • Phenotype
  • Receptors, IgG (metabolism)
  • Receptors, Immunologic (metabolism)
  • Signal Transduction
  • Synoviocytes (drug effects, metabolism, pathology)
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: